Filemon S. Dela Cruz

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Papers

Driven by 24 papers — median percentile 80. Top paper: “A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies”.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

A Bayesian active learning platform for scalable combination drug screens

Nature Communications(2025)10.1038/s41467-024-55287-7

N/A

0.587DataRank · unranked

16 citations

Mauricio Tec, Jessica White, Jeffrey F. Quinn, Glorymar Ibanez Sanchez, Paul Calder +4 more

ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Blood Advances(2021)10.1182/bloodadvances.2020003699

N/A

0DataRank · unranked

13 citations

Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed +7 more

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.03.462951

N/A

0DataRank · unranked

7 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +48 more

Identification and validation of a non-genetically encoded vulnerability to XPO1 inhibition in malignant rhabdoid tumors – expanding patient-driven discovery beyond the N-of-1

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.02.462793

N/A

0DataRank · unranked

1 citations

Daniel Diolaiti, Prabhjot S. Mundi, Ervin S. Gaviria, Allison R. Rainey, Darrell J. Yamashiro +8 more

Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma

Nature Cancer(2022)10.1038/s43018-022-00414-w

N/A

0DataRank · unranked

66 citations

Qian Qin, Chuan Yan, Madeline N. Hayes, Sara P. Garcia, Haibin Xi +16 more

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Science Advances(2022)10.1126/sciadv.abn1382

N/A

0DataRank · unranked

48 citations

Lisa Depestel, Liselot Mus, Kaylee M. Keller, Louis Delhaye, Amber Louwagie +37 more

Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

Nature Communications(2022)10.1038/s41467-022-32023-7

N/A

0DataRank · unranked

29 citations

Fabian F. Pusch, Yi Bei, Jennifer von Stebut, Glorymar Ibáñez, Kristina Guillan +34 more

Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors

Med(2022)10.1016/j.medj.2022.09.002

N/A

0DataRank · unranked

20 citations

Prabhjot S. Mundi, Lianna J. Marks, Chelsey Burke, Michael V. Ortiz, Daniel Diolaiti +17 more

Dynamic Network Curvature Analysis of RNA-Seq Data in Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.09.483487

N/A

0DataRank · unranked

0 citations

Jung Hun Oh, Filemon S. Dela Cruz, Joseph O. Deasy, Andrew L. Kung, Allen Tannenbaum +1 more

Dynamic Network Curvature Analysis of Gene Expression Reveals Novel Potential Therapeutic Targets in Sarcoma

Research Square(2022)10.21203/rs.3.rs-1898863/v1

N/A

0DataRank · unranked

0 citations

Rena Elkin, Jung Hun Oh, Filemon S. Dela Cruz, Larry Norton, Joseph O. Deasy +2 more

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

Cancer Research(2023)10.1158/0008-5472.can-23-0385

N/A

0DataRank · unranked

27 citations

Simone Zaccaria, Alvin P. Makohon-Moore, Brian J. Arnold, Max F. Levine, Gunes Gundem +25 more

FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.30.538578

N/A

0DataRank · unranked

5 citations

Daniel E. Gracilla, Marcus R. Breese, Yone Phar Lin, Filemon S. Dela Cruz, Tamar Y. Feinberg +12 more

Dynamic Network Curvature Analysis of Gene Expression Reveals Novel Potential Therapeutic Targets in Sarcoma

Research Square(2023)10.21203/rs.3.rs-1898863/v2

N/A

0DataRank · unranked

3 citations

Jung Hun Oh, Filemon S. Dela Cruz, Larry Norton, Joseph O. Deasy, Andrew L. Kung +2 more

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.05.522765

N/A

0DataRank · unranked

1 citations

Simone Zaccaria, Alvin P. Makohon-Moore, Brian J. Arnold, Max F. Levine, Gunes Gundem +25 more

Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0110

N/A

0DataRank · unranked

45 citations

Daniel Cameron, Helen S. Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +11 more

Roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials

Cancer(2024)10.1002/cncr.35457

N/A

0DataRank · unranked

4 citations

Jamie M. Aye, Jacquelyn Crane, Sapna Oberoi, Frank M. Balis, Smita Bhatia +18 more

Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcoma

Scientific Reports(2024)10.1038/s41598-023-49930-4

N/A

0DataRank · unranked

4 citations

Jung Hun Oh, Filemon S. Dela Cruz, Larry Norton, Joseph O. Deasy, Andrew L. Kung +2 more

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

Journal of Clinical Investigation(2025)10.1172/jci179282

N/A

0DataRank · unranked

5 citations

Helen S. Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +12 more

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0428

N/A

0DataRank · unranked

3 citations

Elizabeth Stewart, Didier Surdez, Jessica D. Daley, Alice Soragni, Eleni M. Tomazou +24 more

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group

European Journal of Cancer(2025)10.1016/j.ejca.2025.115600

N/A

0DataRank · unranked

1 citations

David P. Douglass, Sapna Oberoi, Natalie B. Collins, Ajay Gupta, Jonathan Metts +17 more

Preclinical evaluation of XPO1 inhibition in Wilms tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3580

N/A

0DataRank · unranked

1 citations

Armaan Siddiquee, Daoqi You, Prabhjot S. Mundi, Lianna J. Marks, Kristina Guillan +6 more

PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.15.633227

N/A

0DataRank · unranked

1 citations

Julia S. Brunner, Jacob A. Boyer, Angela M. Montero, Benjamin T. Jackson, Sangita Chakraborty +10 more

STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma

Cancer Cell(2021)10.1016/j.ccell.2021.05.007

N/A

0DataRank · unranked

125 citations

Gabriela Alexe, Bo Kyung A. Seong, Diana Lu, Elizabeth Hwang, Denes Hnisz +23 more

Filemon S. Dela Cruz

Indexed papers

Top data-sharing exemplar

Papers